Literature DB >> 8061292

Neuronal rescue with transforming growth factor-beta 1 after hypoxic-ischaemic brain injury.

H McNeill1, C Williams, J Guan, M Dragunow, P Lawlor, E Sirimanne, K Nikolics, P Gluckman.   

Abstract

Transforming growth factor-beta 1 (TGF-beta 1) mRNA is induced from 5 h to 3 days following hypoxic-ischaemic brain injury. Cell death also develops during this time suggesting that extracellular accumulation of this peptide may be involved in the processes that regulate cell loss. We examined the effect of rhTGF-beta 1 (0,2.5, 10,50 ng) injected into the cerebral lateral ventricle of rats 2 h after severe hypoxic-ischaemic brain injury. Histological outcome and B4-isolectin histochemistry were assessed 5 and 2 days, respectively following hypoxia. Treatment with 10 ng TGF-beta 1 reduced the microglia reaction (p < 0.05), the magnitude of neuronal loss (p < 0.01) and the area of cortical infarction (p < 0.05). Exogenous TGF-beta 1 given soon after hypoxic-ischaemic brain injury may have therapeutic potential and act by inhibiting the microglial reaction.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8061292     DOI: 10.1097/00001756-199404000-00012

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  19 in total

Review 1.  Blood-brain barrier dysfunction, TGFβ signaling, and astrocyte dysfunction in epilepsy.

Authors:  Uwe Heinemann; Daniela Kaufer; Alon Friedman
Journal:  Glia       Date:  2012-02-29       Impact factor: 7.452

Review 2.  Mechanisms of ischemic brain damage.

Authors:  Kristian P Doyle; Roger P Simon; Mary P Stenzel-Poore
Journal:  Neuropharmacology       Date:  2008-01-25       Impact factor: 5.250

Review 3.  TGF-β Family Signaling in Neural and Neuronal Differentiation, Development, and Function.

Authors:  Emily A Meyers; John A Kessler
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-08-01       Impact factor: 10.005

Review 4.  Stroke and T-cells.

Authors:  Thiruma V Arumugam; D Neil Granger; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

5.  Immunologic tolerance to myelin basic protein decreases stroke size after transient focal cerebral ischemia.

Authors:  K J Becker; R M McCarron; C Ruetzler; O Laban; E Sternberg; K C Flanders; J M Hallenbeck
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

6.  Transforming growth factor-beta1 regulates the fate of cultured spinal cord-derived neural progenitor cells.

Authors:  S M Park; J S Jung; M S Jang; K S Kang; S K Kang
Journal:  Cell Prolif       Date:  2008-04       Impact factor: 6.831

Review 7.  IGF-1 derived small neuropeptides and analogues: a novel strategy for the development of pharmaceuticals for neurological conditions.

Authors:  Jian Guan; Peter D Gluckman
Journal:  Br J Pharmacol       Date:  2009-05-11       Impact factor: 8.739

Review 8.  Vasotrophic regulation of age-dependent hypoxic cerebrovascular remodeling.

Authors:  Jinjutha Silpanisong; William J Pearce
Journal:  Curr Vasc Pharmacol       Date:  2013-09       Impact factor: 2.719

Review 9.  Blood-brain barrier breakdown-inducing astrocytic transformation: novel targets for the prevention of epilepsy.

Authors:  Alon Friedman; Daniela Kaufer; Uwe Heinemann
Journal:  Epilepsy Res       Date:  2009-04-11       Impact factor: 3.045

10.  From death to recovery following hypoxia ischemia: if TGFbeta is a central regulator, is integrin beta8 the switch?

Authors:  Thomas D Arnold; Patrick S McQuillen
Journal:  Neurotox Res       Date:  2010-05       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.